Search research articles
Contact Us
Filters
Showing results (121-130 of 179) with videos related to
Page
of 18
Sort By:
Dalton Transactions (Cambridge, England : 2003)
|
October 20, 2020
An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals
Jaclyn L Lange, Patrick R W J Davey, Michelle T Ma, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 2, 2018
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with <sup>213</sup>Bi-substance P analogue
Leszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2018
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing <sup>225</sup>Ac-PSMA-617 RLT
Hendrik Rathke, Clemens Kratochwil, Ralph Hohenberger, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 17, 2017
A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer
Ekaterina Revskaya, Zewei Jiang, Alfred Morgenstern, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 20, 2025
Ac-225 radiochemistry through the lens of [<sup>225</sup>Ac]Ac-DOTA-TATE
Eline L Hooijman, Jan R de Jong, Carolline M Ntihabose, et al.
Plos One
|
February 12, 2014
DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy
Franziska Graf, Jörg Fahrer, Stephan Maus, et al.
EJNMMI Radiopharmacy and Chemistry
|
April 4, 2025
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with <sup>225</sup>Ac
Kateřina Ondrák Fialová, Lukáš Ondrák, Martin Vlk, et al.
Oncotarget
|
April 28, 2016
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer
Takahiro Yoshida, Kideok Jin, Hong Song, et al.
Cancer Biology & Therapy
|
March 19, 2008
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model
Emma Y Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Biology & Therapy
|
August 19, 2008
Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206
Syed M Abbas Rizvi, Emma Yanjun Song, Chand Raja, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 179) with videos related to
Sort By:
Page
of 18
Dalton Transactions (Cambridge, England : 2003)
|
October 20, 2020
An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals
Jaclyn L Lange, Patrick R W J Davey, Michelle T Ma, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 2, 2018
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with <sup>213</sup>Bi-substance P analogue
Leszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2018
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing <sup>225</sup>Ac-PSMA-617 RLT
Hendrik Rathke, Clemens Kratochwil, Ralph Hohenberger, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 17, 2017
A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer
Ekaterina Revskaya, Zewei Jiang, Alfred Morgenstern, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 20, 2025
Ac-225 radiochemistry through the lens of [<sup>225</sup>Ac]Ac-DOTA-TATE
Eline L Hooijman, Jan R de Jong, Carolline M Ntihabose, et al.
Plos One
|
February 12, 2014
DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy
Franziska Graf, Jörg Fahrer, Stephan Maus, et al.
EJNMMI Radiopharmacy and Chemistry
|
April 4, 2025
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with <sup>225</sup>Ac
Kateřina Ondrák Fialová, Lukáš Ondrák, Martin Vlk, et al.
Oncotarget
|
April 28, 2016
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer
Takahiro Yoshida, Kideok Jin, Hong Song, et al.
Cancer Biology & Therapy
|
March 19, 2008
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model
Emma Y Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Biology & Therapy
|
August 19, 2008
Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206
Syed M Abbas Rizvi, Emma Yanjun Song, Chand Raja, et al.
Page
of 18